Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm鈥檚 product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) ti...